The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Myriad Genetics, Inc.

Myriad Genetics, Inc.
Nasdaq: MYGN
Change
symbol:
     
 NEWS FROM THE WIRES
Sanyo, NEC tie on medical information systems
Aug 21 2001 06:41 PM PDT

Myriad Genetics fiscal Q4 loss narrows
Aug 21 2001 03:48 AM PDT

Canadian premiers wade into gene patenting debate
Aug 03 2001 03:53 PM PDT

Oxford GlycoSciences' machine finds proteins -- fast
Jul 27 2001 02:23 PM PDT

Siemens leads DAX south, baker Kamps plunges on MDAX
Jul 18 2001 03:56 AM PDT

More WIRE STORIES about this company

 NEWS FROM THE STANDARD
Gene Schemes
Jul 16 2001 12:00 AM PDT

IBM's Biotech Ambitions
Jun 04 2001 12:00 AM PDT

IBM Wants to Play Doctor
May 30 2001 12:04 PM PDT

After the Bell: Techs Storm Back
Apr 04 2001 03:54 PM PDT

Myriad, Oracle, Hitachi Team Up to Map Human Proteins
Apr 04 2001 11:15 AM PDT

 PROFILE
Mutants beware: Myriad Genetics is looking for you. The company uses bioinformatic gene mapping, family history analysis, and protein interaction identification (a database called ProNet) to find inherited gene mutations that increase the risk for cancer, heart attacks, and other diseases. The company has tools to determine a patient's risk for breast or ovarian cancer (BRACAnalysis), cardiovascular disease (CardiaRisk), and colon and uterine cancer (COLARTIS). The company has research alliances with several pharmaceutical firms, including Bayer, Eli Lilly, and Schering-Plough. It has teamed with Oracle and Hitachi to map the human proteome, cataloging all human protein interactions and biochemical pathways.

 COMPETITION
Applera Corporation (dossier)
Incyte Genomics, Inc. (INCY)
Millennium Pharmaceuticals, Inc. (MLNM)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: June
2000 Sales (mil.): 34.00
1-Yr. Sales Growth: 34.4%
Employees: 338
Revenue per employee: $100,591.72

 KEY PEOPLE
• Peter D. Meldrum
    CEO
• Jay M. Moyes
    CFO

 CONTACT INFO
320 Wakara Way
Salt Lake City, UT 84108
US
Phone: 801-584-3600
Fax: 801-584-3640
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001